STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
23
Codes C/M, not in net · $0 priced
What the filings say about MSGS
Insiders, 180 days
-$247.3K net sold
1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$247.3K
1 notice
Madison Square Garden Sports insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Madison Square Garden Sports Corp. insiders sold a net $247.3K of stock across 44 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MSGS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Warner Bryan
Filed 2026-09-16
$247.3K
Mink Victoria
Filed 2026-07-16
$1.5M
Executive pay vs shareholder return · Dolan
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$10.2M
$10.1M
$4.3M
+34%
+45%
2021
$8.3M
$7.6M
$5.1M
+3%
+22%
2020
$6.5M
$8.0M
$3.2M
+17%
+130%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $247.3K sold by insiders over 180 days, $247.3K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MSGS
FY Jun 2026
$1.2B
FY Jun 2025
$1.0B
FY Jun 2024
$1.0B
FY Jun 2023
$887.4M
FY Jun 2022
$821.4M
Jun 2026
$278.7M
Mar 2026
$432.2M
Dec 2025
$403.4M
Sep 2025
$39.5M
Jun 2025
$204.0M
Mar 2025
$424.2M
Dec 2024
$357.8M
Sep 2024
$53.3M
At each fiscal year end
Single quarter
Net margin, TTM
+0.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MSGS
FY Jun 2026
+0.7%
FY Jun 2025
-2.2%
FY Jun 2024
+5.7%
FY Jun 2023
+5.4%
FY Jun 2022
+6.2%
Jun 2026
+10.2%
Mar 2026
-4.6%
Dec 2025
+2.0%
Sep 2025
-22.3%
Jun 2025
-0.9%
Mar 2025
-3.4%
Dec 2024
+0.3%
Sep 2024
-14.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$61.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MSGS
FY Jun 2026
$61.3M
FY Jun 2025
$88.0M
FY Jun 2024
$90.7M
FY Jun 2023
$151.3M
FY Jun 2022
$177.1M
Jun 2026
$57.6M
Mar 2026
$57.4M
Dec 2025
$31.6M
Sep 2025
-$85.3M
Jun 2025
$49.4M
Mar 2025
$3.9M
Dec 2024
$61.2M
Sep 2024
-$26.5M
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity MSGS
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.24x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt MSGS
FY Jun 2026
0.24x
FY Jun 2025
0.31x
FY Jun 2024
0.30x
FY Jun 2023
0.47x
FY Jun 2022
0.71x
Jun 2026
0.24x
Mar 2026
0.21x
Dec 2025
0.01x
Sep 2025
0.11x
Jun 2025
0.31x
Mar 2025
0.52x
Dec 2024
0.49x
Sep 2024
0.39x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity MSGS
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MSGS
FY Jun 2026
+0.5%
FY Jun 2025
-1.6%
FY Jun 2024
+4.4%
FY Jun 2023
+3.7%
FY Jun 2022
+3.9%
Jun 2026
+0.5%
Mar 2026
-1.5%
Dec 2025
-1.1%
Sep 2025
-1.6%
Jun 2025
-1.6%
Mar 2025
+0.3%
Dec 2024
+4.1%
Sep 2024
+5.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate 57%, not meaningful
Return on invested capital MSGS
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
+252.3%
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+3.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MSGS
FY Jun 2026
+3.2%
FY Jun 2025
+1.7%
FY Jun 2024
+18.0%
FY Jun 2023
+10.3%
FY Jun 2022
+9.5%
Jun 2026
+3.2%
Mar 2026
-2.9%
Dec 2025
+0.5%
Sep 2025
-0.5%
Jun 2025
+1.7%
Mar 2025
+10.3%
Dec 2024
+17.0%
Sep 2024
+18.9%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
1,239.97x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MSGS
FY Jun 2026
1,296.26x
FY Jun 2025
n/a
FY Jun 2024
77.42x
FY Jun 2023
98.46x
FY Jun 2022
72.25x
Jun 2026
1,296.26x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
927.24x
Dec 2024
95.22x
Sep 2024
71.57x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value MSGS
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield MSGS
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing MSGS
FY Jun 2026
n/a
FY Jun 2025
n/a
FY Jun 2024
2.84x
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
1.98x
Sep 2024
1.25x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MSGS ranks highest on growth (80th percentile) and financial health (62nd), and lowest on risk and compliance (24th), among Restaurants & Leisure peers.
Profitability
44
Inputs
Return on equityaverage equity is zero or negative
Return on assets+0.5% · 45 pct, sector of 120
Return on invested capitaleffective tax rate 57%, not meaningful
Return on capital employed+3.2% · 44 pct, sector of 104
Financial health
62
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt0.24x · 62 pct, sector of 105
Growth
80
Inputs
Revenue growth, YoY+11.0% · 73 pct, sector of 143
Backlog growth, YoY+32.3% · 88 pct, sector of 33
Insider conviction
32
Inputs
Net Form 4 buying (codes P and S), 180d-$247K · 64 pct, sector of 77
Insider buyers, 180d0 · 0 pct, sector of 77
Risk and compliance
24
Inputs
Short interest, % of float+9.8% · 35 pct, sector of 150
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+24.4% · 12 pct, sector of 100
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MSGS filings, in plain words
Are Madison Square Garden Sports insiders buying or selling MSGS?
In the 180 days to 2026-10-28, Madison Square Garden Sports insiders were net sellers, a net $247.3K across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of MSGS?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $247.3K of stock; the latest, by Warner Bryan, was filed 2026-09-16.
Read the full summary
In the 180 days to 2026-10-28, Madison Square Garden Sports insiders were net sellers of MSGS, a net $247.3K across purchases and sales reported on Form 4 by 1 seller. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $247.3K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.